Live
ePaper
Search
Home > India > UPDATE 1-US FDA approves Regeneron's drug for generalized myasthenia gravis

UPDATE 1-US FDA approves Regeneron's drug for generalized myasthenia gravis

Written By:
Last Updated: November 19, 2026 04:56:37 IST

(Adds details in paragraphs 2 to 4) Nov 18 (Reuters) – The US Food and Drug Administration has approved Regeneron Pharmaceuticals' drug to treat adults with a type of rare autoimmune disease called

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?